'Eli Lilly-Children International' launches Teen Campaign to reduce TB cases in India

14 August 2009

US drug major Eli Lilly, through its Lilly MDR TB Partnership and Children International have launched a yearlong public awareness campaign aimed to bolster the TB eradication in India. Lilly MDR TB Partnership, with the support of the local government, hopes the campaign will empower the teen community with necessary resources to help reach out to the 800 community members residing in two high risk neighborhoods of Kolkata.

"The objective of the campaign is to prevent patients dropping out of treatment programs besides providing all round disease awareness, support and motivation for TB patients to complete their treatment with a practical approach," said Ramdas Pai, Regional Director, Asia, Children International.

Under the program, 15-20 motivated trained teens will be trained to become 'Youth Peer Educators' or YPEs who will then use a variety of health education techniques, including street theater, school presentations and discussions, and one-on-one counseling to educate the community.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight